Minimize chemistry manufacturing controls risk in scale-up | Cytiva

{{main.productCount}} {{main.productCount}}

Your Cart
Showing {{main.getNumberOfShowingResults(main.products)}} of {{main.products.length}} items

You don't have any items in your cart yet.

{{item.qty}} x {{item.productName}} Product Code: {{item.catalogCode}} Pack Size: {{item.packSize}} Price: {{item.price}} {{item.unitPrice}} {{item.currency}}

Subtotal

{{main.subtotal}} {{main.currency}}

Checkout now

Access expertise early on and de-risk process milestones

Manufacturing novel biotherapeutics poses complex challenges that can make it difficult to meet milestones without taking on unexpected risk. You need a robust process, a secure supply chain, and a way to minimize production deviations so patients receive high-quality therapies each time. Early design choices can affect your overall speed to market. Build your expertise with ours.

Learn how to manage raw materials and process risks in biomanufacturing.

Scale up | Process development resources | Application solutions

Accelerate your process from bench to trials

It is not straightforward to scale molecules to meet regulatory and patient demand. While you’ve mastered the science of therapeutic innovation, we’ve mastered the art of bioprocessing, with decades of experience taking companies from start-up to clinicals trial and commercial success. Together, we can help you reduce risk and make good decisions faster.

Optimizing process efficiency in upstream manufacturing.

Translating biopharma knowledge to cell and gene therapies.

Process development resources

Scaling up bioprocesses through a CDMO

Roivant Sciences and Cytiva’s Fast Trak services collaborate to accelerate an orphan drug to clinic.

Illustration of an operating window for aeration and agitation.

Scaling a mAb process to 1000 L

Translating monoclonal antibody production from microscale to 1000 L.

Moving from non GMP to GMP

Transferring a process from a laboratory-scale idea to GMP-compliant commercial product.

Upstream lentivirus viable cell density and viability small scale

Lentiviral vector scale-up

Simple batch process scales in linear manner from 5 L to 28 L in single-use bioreactors.

Speeding upstream process development

Process intensification and other approaches to increase efficiency.

Image to illustrate tech transfer bioprocess technology transfer

CDMO technology transfer success

Don’t risk reducing the quality and efficiency of your process during handoff.

Application solutions

Scientists in the lab with Äkta go

Protein production

Upstream, downstream, and analytics support to take you from idea to pure characterized product.

Cell processing

Technologies to close, automate, and digitize your cell therapy process for consistent and scalable production.

Gene therapy

Flexible, scalable solutions to help you quickly add capacity to develop and manufacture your own plasmids and viral vectors.

Accelerate process development

Balancing innovation, speed, and robustness to support biotherapeutic production.